Comparative effects of fish oil supplementation and a leukotriene receptor antagonist [montelukast] on EIB [exercise-induced bronchoconstriction] and airway inflammation in asthma

Trial Profile

Comparative effects of fish oil supplementation and a leukotriene receptor antagonist [montelukast] on EIB [exercise-induced bronchoconstriction] and airway inflammation in asthma

Completed
Phase of Trial: Phase I

Latest Information Update: 14 Oct 2009

At a glance

  • Drugs Eicosapentaenoic acid/docosahexaenoic acid; Montelukast
  • Indications Asthma
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Oct 2009 Actual end date (Apr 2009) added as reported by ClinicalTrials.gov.
    • 14 Oct 2009 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
    • 03 Jun 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top